Earnings · Hong Kong stocks

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class H (2196) earnings

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class H published its quarterly report on 2026-08-25: net profit -8.60% year on year. The stock moved -1.43% in the 3 trading days after the report.

Report
quarterly report
Published
2026-08-25
Net profit YoY
-8.60%
Result
Neutral
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day+3.04%—
3 days-1.43%—
7 days-5.77%—
14 days-2.80%—
30 days+8.87%—

Report history

Over the last 8 reports, EPS beat the consensus estimate in 4 of them. The stock rose in the 3 trading days after 5 of 8 reports (average +1.00%).

PublishedEPS YoYEPSEPS surprise3 days after30 days after30d vs index
2026-08-25-8.60%0.32-9.86%-1.43%+8.87%+12.95%
2026-04-28+13.80%0.33—-4.16%-19.39%-14.08%
2026-03-25+10.30%0.32+10.34%+8.67%+6.47%+1.82%
2025-10-28+6.90%0.31+3.33%+2.96%-3.04%+1.70%
2025-08-26—0.35+27.27%+1.40%+18.94%+13.63%
2025-04-29+625.00%0.29-6.45%-3.99%+20.66%+10.18%
2025-03-25+625.00%0.29+13.73%+2.80%-7.32%-5.63%
2024-10-29+52.60%0.29-1.69%+1.78%-2.06%+2.33%

The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.

Stock valuations: 2196

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.